New options for bronchodilator treatment in COPD.

Transplant 1999;18:884e90. 12. Dahele M, Ung Y, Meharchand J, et al. Integrating regional and community lung cancer services to improve patient care. Curr Oncol 2007;14:234e7. 13. Murray SA, Boyd K, Sheikh A. Palliative care in chronic illness. BMJ 2005;330:611e12. 14. Hofer M. Advanced chronic lung disease: need for an active interdisciplinary approach. Swiss Med Wkly 2007;137:593e601. 15. Raghu G. Improving the standard of care for patients with idiopathic pulmonary fibrosis requires participation in clinical trials. Chest 2009;136:330e33. 16. Raghu G, Brown KK, Bradford WZ, et al. A placebocontrolled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125e33. 17. Azuna A, Nukiwa T, Tsuboi E, et al. Double-blind placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:636e43. 18. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229e42. 19. Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005;128:1475e82. 20. Varney VA, Parnell HM, Salisbury DT, et al. A double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced fibrotic lung disease. Pulm Pharmacol Ther 2008;21:178e87. 21. Horton MR, Danoff SK, Lechtzin N. Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis. Thorax 2008;63:749. 22. Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136e42. 23. Gribbin J, Hubbard R, Smith C. Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med 2009;103:927e31. 24. Swigris JJ, Brown KK, Make BJ, et al. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med 2008;102:1675e80.